Golden State Wealth Management LLC Purchases New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Golden State Wealth Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,545 shares of the medical equipment provider’s stock, valued at approximately $806,000.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC raised its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC boosted its stake in shares of Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. grew its holdings in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $588.50 on Friday. The company has a market capitalization of $209.61 billion, a price-to-earnings ratio of 91.81, a PEG ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company has a 50-day simple moving average of $553.03 and a two-hundred day simple moving average of $512.59.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,940 shares of company stock worth $3,333,485 in the last 90 days. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent research reports. Citigroup lifted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Finally, Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.